Observational Study of the Use of Recombinant Tissue-Type Plasminogen Activator in COVID-19 Shows a Decrease in Physiological Dead Space

Abstract

Tweetable abstract @ERSpublications click to tweet#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a

Publication
ERJ Open Research